In the latest session, Clorox Co. (NYSE: CLX) closed at $144.02 down -0.23% from its previous closing price of $144.35. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 1460960 shares were traded.
Ratios:
For a deeper understanding of Clorox Co.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.55. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 59.04 whereas as Long-Term Debt/Eq ratio is at 52.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on April 02, 2024, Downgraded its rating to Neutral and sets its target price to $165 from $170 previously.
On March 26, 2024, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $145.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 14 ’23 when Jacobsen Kevin B sold 3,346 shares for $160.82 per share. The transaction valued at 538,096 led to the insider holds 23,224 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 17.87B and an Enterprise Value of 20.65B. As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 226.34, and their Forward P/E ratio for the next fiscal year is 22.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 16.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.45 while its Price-to-Book (P/B) ratio in mrq is 337.17. Its current Enterprise Value per Revenue stands at 2.82 whereas that against EBITDA is 42.22.
Stock Price History:
Over the past 52 weeks, CLX has reached a high of $178.21, while it has fallen to a 52-week low of $114.68. The 50-Day Moving Average of the stock is 151.29, while the 200-Day Moving Average is calculated to be 145.27.
Shares Statistics:
For the past three months, CLX has traded an average of 1.24M shares per day and 1.09M over the past ten days. A total of 124.11M shares are outstanding, with a floating share count of 123.84M. Insiders hold about 0.21% of the company’s shares, while institutions hold 81.25% stake in the company. Shares short for CLX as of Mar 28, 2024 were 3.55M with a Short Ratio of 2.52, compared to 4.08M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.86% and a Short% of Float of 3.26%.
Dividends & Splits
According to the company, the forward annual dividend rate for CLX is 4.78, from 2.38 in the trailing year. Against a Trailing Annual Dividend Yield of 1.65%, it implies a Forward Annual Dividend Yield of 3.33%. The stock’s 5-year Average Dividend Yield is 2.77. The current Payout Ratio is 395.03% for CLX, which recently paid a dividend on May 10, 2024 with an ex-dividend date of Apr 23, 2024. Stock splits for the company last occurred on Aug 24, 1999 when the company split stock in a 2:1 ratio.
Earnings Estimates
There are 14 different market analysts currently analyzing its stock. On average, analysts expect EPS of $1.41 for the current quarter, with a high estimate of $1.87 and a low estimate of $1.24, while EPS last year was $1.51. The consensus estimate for the next quarter is $1.57, with high estimates of $1.78 and low estimates of $1.3.
Analysts are recommending an EPS of between $6.21 and $5.39 for the fiscal current year, implying an average EPS of $5.61. EPS for the following year is $6.43, with 18 analysts recommending between $6.9 and $5.59.
Revenue Estimates
A total of 16 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $7.44B, while the lowest revenue estimate was $7.13B, resulting in an average revenue estimate of $7.25B. In the same quarter a year ago, actual revenue was $7.39B, down -1.90% from the average estimate. Based on 18 analysts’ estimates, the company’s revenue will be $7.51B in the next fiscal year. The high estimate is $7.66B and the low estimate is $7.21B. The average revenue growth estimate for next year is up 3.70% from the average revenue estimate for this year.
